Loading insider details...
Beta
Latest Form 4 (Jun 10, 2026): Grant/Award of 34,517 OPRX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 10, 2026 | OptimizeRx Corp (OPRX) | Grant/Award | 34,517 | n/a |
| Aug 8, 2025 | P3 Health Partners Inc. (PIII) | Grant/Award | 2,000 | n/a |
| Jun 12, 2025 | OptimizeRx Corp (OPRX) | Grant/Award | 9,868 | n/a |
| Jun 11, 2024 | OptimizeRx Corp (OPRX) | Exercise/Conversion | 10,061 | n/a |
| Jun 10, 2024 | P3 Health Partners Inc. (PIII) | Grant/Award | 482,640 | n/a |
| Jan 25, 2024 | P3 Health Partners Inc. (PIII) | Grant/Award | 216,561 | n/a |
| Aug 18, 2023 | OptimizeRx Corp (OPRX) | Exercise/Conversion | 4,637 | n/a |
| Apr 3, 2023 | OptimizeRx Corp (OPRX) | Exercise/Conversion | 657 | n/a |
| Jan 4, 2023 | OptimizeRx Corp (OPRX) | Exercise/Conversion | 409 | n/a |
| Sep 30, 2022 | OptimizeRx Corp (OPRX) | Exercise/Conversion | 334 | n/a |